Northern Trust Corp Merrimack Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.06 - $15.0 $8,345 - $9,585	639 Added 0.55%	117,548 $1.74 Million
Q4 2023 Feb 13, 2024	BUY	$12.02 - $13.41 $18,510 - $20,651	1,540 Added 1.33%	116,909 $1.57 Million
Q3 2023 Nov 13, 2023	SELL	$11.6 - $12.52 $7,226 - $7,799	-623 Reduced 0.54%	115,369 $1.42 Million
Q2 2023 Aug 11, 2023	BUY	$12.02 - $13.07 $1.06 Million - $1.15 Million	88,044 Added 315.03%	115,992 $1.43 Million
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $24,130 - $26,192	2,126 Added 8.23%	27,948 $343,000
Q4 2022 Feb 13, 2023	BUY	$3.68 - $12.51 $6,778 - $23,043	1,842 Added 7.68%	25,822 $295,000
Q3 2022 Nov 14, 2022	BUY	$3.7 - $6.06 $654 - $1,072	177 Added 0.74%	23,980 $90,000
Q2 2022 Aug 12, 2022	SELL	$4.89 - $7.13 $6,161 - $8,983	-1,260 Reduced 5.03%	23,803 $142,000
Q1 2022 May 13, 2022	SELL	$3.75 - $6.82 $330 - $600	-88 Reduced 0.35%	25,063 $159,000
Q3 2021 Nov 15, 2021	SELL	$4.3 - $6.39 $28,066 - $41,707	-6,527 Reduced 20.6%	25,151 $121,000
Q2 2021 Aug 13, 2021	SELL	$6.04 - $7.77 $27,391 - $35,236	-4,535 Reduced 12.52%	31,678 $203,000
Q1 2021 May 12, 2021	BUY	$6.15 - $8.7 $1,986 - $2,810	323 Added 0.9%	36,213 $228,000
Q4 2020 Feb 11, 2021	SELL	$3.69 - $8.31 $2,737 - $6,166	-742 Reduced 2.03%	35,890 $247,000
Q3 2020 Nov 16, 2020	SELL	$3.1 - $4.3 $15,977 - $22,162	-5,154 Reduced 12.33%	36,632 $146,000
Q2 2020 Aug 14, 2020	SELL	$2.21 - $3.88 $83,721 - $146,986	-37,883 Reduced 47.55%	41,786 $139,000
Q1 2020 May 14, 2020	SELL	$1.63 - $3.58 $215 - $472	-132 Reduced 0.17%	79,669 $171,000
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $456 - $677	-145 Reduced 0.18%	79,801 $251,000
Q3 2019 Nov 13, 2019	SELL	$4.16 - $6.05 $5,079 - $7,387	-1,221 Reduced 1.5%	79,946 $360,000
Q2 2019 Aug 13, 2019	BUY	$4.39 - $5.66 $522 - $673	119 Added 0.15%	81,167 $491,000
Q1 2019 May 13, 2019	BUY	$3.19 - $5.73 $65,812 - $118,215	20,631 Added 34.15%	81,048 $563,000
Q4 2018 Feb 12, 2019	BUY	$2.95 - $4.15 $30,275 - $42,591	10,263 Added 20.46%	60,417 $233,000
Q3 2018 Nov 14, 2018	BUY	$3.91 - $4.66 $2,564 - $3,056	656 Added 1.33%	50,154 $267,000
Q2 2018 Sep 18, 2018	SELL	$3.86 - $7.61 $3,362 - $6,628	-871 Reduced 1.73%	49,498 $243,000
Q2 2018 Aug 14, 2018	SELL	$3.86 - $7.61 $421,156 - $830,311	-109,108 Reduced 68.42%	50,369 $248,000
Q1 2018 May 09, 2018	BUY	$6.24 - $9.15 $62,125 - $91,097	9,956 Added 6.66%	159,477 $1.28 Million
Q4 2017 Feb 14, 2018	BUY	$7.99 - $11.87 $10,946 - $16,261	1,370 Added 0.92%	149,521 $1.53 Million
Q3 2017 Nov 13, 2017	BUY	$9.13 - $11.72 $1.35 Million - $1.74 Million	148,151	148,151 $2.15 Million

Others Institutions Holding MACK

# of Institutions

Shares Held

349

Call Options Held

Put Options Held

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account